Emergent BioSolutions, Inc.
(NYSE : EBS)

( )
EBS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.43%67.830.0%$2160.77m
NVAXNovavax, Inc. 7.12%133.2896.5%$1099.89m
SRNESorrento Therapeutics, Inc. 4.84%13.011.5%$766.56m
GILDGilead Sciences, Inc. -0.96%68.181.0%$565.93m
AMGNAmgen, Inc. -0.52%240.461.3%$482.60m
REGNRegeneron Pharmaceuticals, Inc. -0.24%610.892.7%$398.24m
VRTXVertex Pharmaceuticals, Inc. -1.37%267.151.9%$362.41m
BNTXBioNTech SE 2.74%71.000.0%$360.46m
BIIBBiogen, Inc. -1.60%288.541.6%$349.87m
ILMNIllumina, Inc. 2.73%353.533.5%$347.55m
VXRTVaxart, Inc. -1.20%9.090.0%$259.39m
ATNMActinium Pharmaceuticals, Inc. 3.77%9.9113.3%$238.86m
EBSEmergent BioSolutions, Inc. 4.17%134.976.4%$195.92m
ALXNAlexion Pharmaceuticals, Inc. -0.87%101.892.0%$166.39m
MCRBSeres Therapeutics, Inc. 21.31%28.583.6%$165.23m

Company Profile

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.